Accelerating Development.

Delivering Results.

We connect sponsors, sites, and patients through advocacy-driven strategies that improve recruitment, retention, and real-world trial performance.

Our Purpose: Bridging Science, Community and Care

Acceltx exists to solve the fundamental challenge facing clinical development: connecting patients to potentially life-changing therapies through trust, advocacy, and community engagement.

Patient-Centered Approach

We make participation seamless and supportive—helping patients stay informed, engaged, and confident from first contact to their final visit.

Community Connection

Our advocates reach patients where they are—activating referral pathways and community partnerships that expand access beyond traditional site boundaries.

Accelerated Development

We bridge operational gaps that slow enrollment—linking qualified participants to the right studies quickly and sustaining engagement through study completion.

We connect the right patients to the right trials at the right time, accelerating development while building trust that lasts well beyond the final study visit.

Clinical Trial Industry Growth

Volume Surges Across All Metrics

460k+

Global Trial Volume

Total trials registered as of 2025, nearly doubling from approximately 250,000 in 2017

20K

Annual Trial Starts

Approximate number of new trials registered globally each year

44%

More Sites per Trial

Average number of clinical trial sites per study has increased over past decade

8-10%

Annual Industry Growth

Industry-sponsored trials have grown 8-10% annually over the past five years

Sources: WHO International Clinical Trials Registry Platform (ICTRP, 2024); NIH ClinicalTrials.gov Trends (2023); IQVIA Institute Global Trends in R&D (2023); Grand View Research Clinical Trials Market Report (2024); Citeline and Clinical Trials Arena Industry Analysis (2024).

The Patient Trust Crisis

Where Clinical Trials Break Down

Today’s clinical trial ecosystem faces unprecedented patient-centered bottlenecks that continue to delay development timelines and increase operational costs. The disconnect between patients, providers, and trial infrastructure represents the industry’s most critical barrier to success.

25%

Extended Timelines

20–30% increase in patient recruitment timelines since 2019—putting added pressure on already overburdened sites

80%

Enrollment Failures

80% of clinical trials fail to meet their original enrollment timelines—delaying development and increasing trial costs

55%

Critical Bottleneck

55% of clinical trials are delayed due to recruitment and retention challenges driven in part by a lack of patient trust

The barrier is access, not science.
Key Opinion Leaders are oversubscribed and often inaccessible when programs need them most

Sources: IQVIA Institute Global Trends in R&D (2023); Tufts CSDD Protocol Design and Performance Benchmarks; NIH National Cancer Institute Clinical Trial Accrual and Retention Resources; CenterWatch State of the Clinical Trials Industry; CTTI Recruitment Reports; Milken Institute Building Trust in Clinical Trials (2023).

Acceltx is not a vendor—we are a partner

We deliver tailored clinical development support for programs that demand more than standard recruitment. Our team engages underrepresented communities, underserved sites, and patients often missed by traditional models.

We embed advocacy where it matters most—guiding patients, caregivers, and sites from trial consideration through completion with clarity, compassion, and clinical precision.

Embedded, Study-Specific Advocacy

Integrated advocates ensure continuity, communication, and retention from first contact to last-patient-last-visit.

Trust-Centered Patient Engagement

Building confidence through consistent, clinically informed communication that keeps patients and caregivers engaged.

Community Education and Referral Pathways

Establishing trusted referral networks that reach patients where they live and receive care.

Key Opinion Leader Engagement

Partnering with experts others are unable to engage to leverage influence and accelerate progress.

Our core belief: Every patient, caregiver, and site is unique—and deserves individualized support, not a template.

Why Choose Acceltx

We focus where trials break down: patient trust, site burden, and community disconnect.

No templates, ever
Every engagement is built from the ground up—guided by referral patterns, community health dynamics, and unmet advocacy needs.

Integrated from referral to retention
We work side-by-side with sites and referring providers to support patients from first contact through last-patient-last-visit.

Aligned patient and caregiver support
Our clinical and advocacy teams collaborate to deliver cohesive, confidence-building support that improves recruitment and retention.

Execution without handoff
We remain actively involved through last-patient-last-visit, ensuring continuity, accountability, and measurable results.

Our mission is to ensure patients and families are seen, heard, and supported—from diagnosis to trial completion. We amplify advocacy where it doesn’t exist and extend its impact where it does.

Measurable Results That Outperform Industry Benchmarks

Turning Insight Into Execution That Delivers

Our data-driven approach consistently exceeds industry standards across critical trial metrics. These results represent averaged performance across Acceltx’s five most recently supported clinical programs in rare disease and complex therapeutic areas.

106%

Recruitment vs. Goal

Exceeded enrollment targets in high-barrier trials requiring specialized patient identification

Industry benchmark: 80-85%

94%

Patient Retention

Sustained retention through personalized support and continuous advocacy engagement

Industry benchmark: 70-85%

67%

Screening-to-Enrollment

High conversion rates driven by community-based patient identification and preparation protocols

Industry benchmark: 35-50%

93%

Sites Screened

Efficient site activation through targeted support and comprehensive engagement frameworks

Industry benchmark: 60-75% (rare disease)

Acceltx drives trial success by embedding operational intelligence across the full engagement continuum—bridging science, care, and community with measurable precision.

*Metrics shown are averaged across Acceltx’s five most recently supported clinical programs

Let Us Accelerate What Matters—Together

Every trial represents hope for patients waiting for answers. Acceltx ensures that hope reaches the people who need it — faster, with trust, clarity, and compassion.

We do not wait for patients to appear. We go out, find them, guide them, and help them stay the course — from first contact to last visit.

Ready to Get Started?

Email: info@acceltx.com

Accelerating Development. Delivering Results.